BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38373978)

  • 1. Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy.
    He Z; Shi J; Zhu B; Tian Z; Zhang Z
    BMC Cancer; 2024 Feb; 24(1):229. PubMed ID: 38373978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
    Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.
    Chen P; Duan Y; Lu X; Chen L; Zhang W; Wang H; Hu R; Liu S
    Cancer Immunol Immunother; 2021 Nov; 70(11):3261-3275. PubMed ID: 33837850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
    Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
    Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway.
    Liu Y; Qu HC
    J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
    Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
    Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3.
    Wang J; Wan H; Mi Y; Wu S; Li J; Zhu L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
    Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
    J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.
    Yang WH; Ding CC; Sun T; Rupprecht G; Lin CC; Hsu D; Chi JT
    Cell Rep; 2019 Sep; 28(10):2501-2508.e4. PubMed ID: 31484063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
    Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
    BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.